A Novel AKR1C3 Specific Prodrug TH3424 With Potent Antitumor Activity in Liver Cancer-Reference-Cited by-同舟云学术

A Novel AKR1C3 Specific Prodrug TH3424 With Potent Antitumor Activity in Liver Cancer

Published:2021-03-10 Issue:1 Volume:110 Page:229-237
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

He Ping¹²,Wang Chunnian³,Wang Yanlan¹²,Wang Caiyan⁴,Zhou Changhua¹²,Cao Donglin⁵,Li Jiang⁶,Bushnell David A.⁷,Li Qing¹²,Kornberg Roger D.²⁷,Xie Wei²⁸,Wang Zhong¹²

Affiliation:

1. School of Pharmaceutical Sciences Sun Yat‐Sen University Guangzhou China

2. Centre for Cellular & Structural Biology Sun Yat‐Sen University Guangzhou China

3. Shanghai Institute for Advanced Immunochemical Studies Shanghai Tech University Shanghai China

4. International Institute for Translational Chinese Medicine Guangzhou University of Chinese Medicine Guangzhou China

5. Department of Laboratory Medicine Guangdong No. 2 Provincial People’s Hospital Guangzhou China

6. State Key Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine Sun Yat‐Sen University Guangzhou China

7. Department of Structural Biology Stanford University Stanford California USA

8. MOE Key Laboratory of Gene Function and Regulation School of Life Sciences Sun Yat‐Sen University Guangzhou China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2171

Reference33 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F.;Cancer J. Clin.,2018

2. Hepatocellular carcinoma pathogenesis: from genes to environment;Farazi P.A.;Nat. Rev. Cancer,2006

3. Molecular targeted therapies in hepatocellular carcinoma;Llovet J.M.;Hepatology,2008

4. The present and the future landscape of treatment of advanced hepatocellular carcinoma;Rimassa L.;Dig. Liver Dis.,2010

5. Sorafenib in advanced hepatocellular carcinoma;Llovet J.M.;N. Engl. J. Med.,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies;Frontiers in Pharmacology;2024-03-08